Please use this identifier to cite or link to this item: https://cuir.car.chula.ac.th/handle/123456789/62172
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSermsiri Sangroongruangsri-
dc.contributor.authorUsa Chaikledkaew-
dc.contributor.authorSuthasinee Kumluang-
dc.contributor.authorWu, Olivia-
dc.contributor.authorGeue, Claudia-
dc.contributor.authorTanapat Ratanapakorn-
dc.contributor.authorPattara Leelahavarong-
dc.contributor.authorLily Ingsrisawang-
dc.contributor.authorPaisan Ruamviboonsuk-
dc.contributor.authorWongsiri Taweebanjongsin-
dc.contributor.authorJanejit Choovuthayakorn-
dc.contributor.authorApichart Singalavanija-
dc.contributor.authorPrut Hanutsaha-
dc.contributor.authorKittisak Kulvichit-
dc.contributor.authorThitiporn Ratanapojnard-
dc.contributor.authorWarapat Wongsawad-
dc.contributor.authorYot Teerawattananon-
dc.contributor.otherChulalongkorn University. Faculty of Medicine-
dc.date.accessioned2019-06-20T11:26:36Z-
dc.date.available2019-06-20T11:26:36Z-
dc.date.issued2018-09-
dc.identifier.citationClinical Drug Investigation. vol.38, no.9 (Sep., 2018), p.853-865en_US
dc.identifier.issn1173-2563 (print)-
dc.identifier.issn1179-1918 (online)-
dc.identifier.urihttp://cuir.car.chula.ac.th/handle/123456789/62172-
dc.description.abstractBackground : There is very limited evidence examining serious systemic adverse events (SSAEs) and post-injection endophthalmitis of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) treatments in Thailand and low- and middle-income countries. Moreover, findings from the existing trials might have limited generalizability to certain populations and rare SSAEs. Objectives : This prospective observational study aimed to assess and compare the safety profiles of IVB and IVR in patients with retinal diseases in Thailand. Methods : Between 2013 and 2015, 6354 patients eligible for IVB or IVR were recruited from eight hospitals. Main outcomes measures were prevalence and risk of SSAEs, mortality, and endophthalmitis during the 6-month follow-up period. Results : In the IVB and IVR groups, 94 and 6% of patients participated, respectively. The rates of outcomes in the IVB group were slightly greater than in the IVR group. All-cause mortality rates in the IVB and IVR groups were 1.10 and 0.53%, respectively. Prevalence rates of endophthalmitis and non-fatal strokes in the IVB group were 0.04% of 16,421 injections and 0.27% of 5975 patients, respectively, whereas none of these events were identified in the IVR group. There were no differences between the two groups in the risks of mortality, arteriothrombotic events (ATE), and non-fatal heart failure (HF). Adjustment for potential confounding factors and selection bias using multivariable models for time-to-event outcomes and propensity scores did not alter the results. Conclusions : The rates of SAEs in both groups were low. The IVB and IVR treatments were not associated with significant risks of mortality, ATE, and non-fatal HF.en_US
dc.language.isoenen_US
dc.publisherSpringer International Publishingen_US
dc.relation.urihttps://doi.org/10.1007/s40261-018-0678-5-
dc.relation.urihttps://link.springer.com/article/10.1007%2Fs40261-018-0678-5-
dc.rights© 2018, The Author(s).en_US
dc.titleReal-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand : A Prospective Observational Studyen_US
dc.typeArticleen_US
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorKittisak.K@Chula.ac.th-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.email.authorNo information provided-
dc.identifier.DOI10.1007/s40261-018-0678-5-
Appears in Collections:Foreign Journal Article

Files in This Item:
File Description SizeFormat 
html_submission_64992.htmlLink to Fulltext2.82 kBHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.